Gunjan Surendranath

Head of Marketing (Franco Market - International Business)

Role: Assistant General Manager at Ajanta Pharma Ltd
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

Manufacturing & ProductionView LinkedIn profile

About Gunjan Surendranath

Handling the biggest portfolio of 100crs in cardiac and diabetes segment. Expertise in building big brands & managing PLC through scientific program and marketing driven campaign.

Experience

Assistant General Manager
Ajanta Pharma Ltd
Apr 2023 — Present · Mumbai, IN

Education

Shri Shivaji Science College
Bachelor of Pharmacy - BPharm, Pharmacy
Indian Institute of Management Bangalore
Digital Marketing for Business Growth
SIESCOMS
Master of Business Administration (M.B.A.), Marketing/Marketing Management, General
2006 — 2008

Skills

Market Research
Pharmaceutical Sales
Pharmaceutical Industry
Market Analysis
Competitive Analysis

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@ajantapharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Ajanta Pharma Ltd

Pharmaceutical Manufacturing · 10K employees · Founded 1973 · Ajanta Tower, 54-A, M Vasanji Road, Chakala, Andheri (E), IN

Ajanta Pharma Limited is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology, and Pain management. Recently Ajanta also got into two new promising therapies of Nephrology and Gynaecology. Its brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 30th Mar 2026, Ajanta has 49 ANDA approvals, out of which 49 are commercialised. It is awaiting US FDA approval for 19 ANDAs. Company plans to file 8-12 ANDAs every year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 850 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.

ajantapharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Gunjan Surendranath

Experience

Assistant General Manager

Education

Shri Shivaji Science College

Indian Institute of Management Bangalore

SIESCOMS

Skills

Find verified contacts for anyone on LinkedIn